SITE009-0143

SITE009 (AUS) › SITE009-0143

SITE009-0143

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-02-14

enrolled

AEs

8

Serious

0

Dropout signal

–

Adverse events

8

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-01-13 (study day 141); relationship: not assessed

moderate assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-01-06 (study day 134); relationship: not assessed

mild assessed

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-12-29 (study day 126); relationship: not assessed

mild assessed

Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-12-19 (study day 116); relationship: not assessed

mild assessed

Grade 3 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-18 (study day 85); relationship: not assessed

severe assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-11-06 (study day 73); relationship: NOT RELATED

mild assessed

Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-11-04 (study day 71); relationship: not assessed

moderate assessed

Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-09-30 (study day 36); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.